Literature DB >> 24096610

Fatty acid profiles in Leishmania spp. isolates with natural resistance to nitric oxide and trivalent antimony.

Alana Freire de Azevedo1, Jorge Luís de Lisboa Dutra, Micheli Luize Barbosa Santos, Darlisson de Alexandria Santos, Péricles Barreto Alves, Tatiana Rodrigues de Moura, Roque Pacheco de Almeida, Marcelo Ferreira Fernandes, Ricardo Scher, Roberta Pereira Miranda Fernandes.   

Abstract

Fatty acids, especially those from phospholipids (PLFA), are essential membrane components that are present in relatively constant proportions in biological membranes under natural conditions. However, under harmful growth conditions, such as diseases, environmental changes, and chemical exposure, the fatty acid proportions might vary. If such changes could be identified and revealed to be specific for adverse situations, they could be used as biomarkers. Such biomarkers could facilitate the identification of virulence and resistance mechanisms to particular chemotherapeutic agents. Therefore, specific biomarkers could lead to better therapeutic decisions that would, in turn, enhance treatment effectiveness. The objective of this study was to compare the fatty acid profiles of trivalent antimony and nitric oxide (NO)-resistant and -sensitive Leishmania chagasi and Leishmania amazonensis isolates. Fatty acid methyl esters (FAMEs) were obtained from total lipids (MIDI), ester-linked lipids (ELFA), and ester-linked phospholipids (PLFA). FAMEs were analyzed by chromatography and mass spectrometry. Species- or resistance-associated differences in FAME profiles were assessed by nonmetric multidimensional scaling, multiresponse permutation procedures, and indicator species analyses. The isolate groups had different MIDI-FAME profiles. However, neither the ELFA nor PLFA profiles differed between the sensitive and resistant isolates. Levels of the fatty acid 18:1 Δ9c were increased in sensitive isolates (p < 0,001), whereas the fatty acid 20:4 Δ5,8,11,14 showed the opposite trend (p < 0.01). We conclude that these two fatty acids are potential biomarkers for NO and antimony resistance in L. chagasi and L. amazonensis and that they could be helpful in therapeutic diagnoses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24096610     DOI: 10.1007/s00436-013-3621-y

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  26 in total

1.  Microbial community dynamics associated with rhizosphere carbon flow.

Authors:  Jessica L Butler; Mark A Williams; Peter J Bottomley; David D Myrold
Journal:  Appl Environ Microbiol       Date:  2003-11       Impact factor: 4.792

2.  Leishmania spp.: mechanisms of toxicity of nitrogen oxidation products.

Authors:  J Mauël; A Ransijn
Journal:  Exp Parasitol       Date:  1997-10       Impact factor: 2.011

3.  Highly specific methyl-end fatty-acid desaturases of trypanosomatids.

Authors:  Andrés Alloatti; Antonio D Uttaro
Journal:  Mol Biochem Parasitol       Date:  2010-10-23       Impact factor: 1.759

Review 4.  Sphingolipids in parasitic protozoa.

Authors:  Kai Zhang; James D Bangs; Stephen M Beverley
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Polyene antibiotic action on lecithin liposomes: effect of cholesterol and fatty acyl chains.

Authors:  C C HsuChen; D S Feingold
Journal:  Biochem Biophys Res Commun       Date:  1973-04-16       Impact factor: 3.575

6.  Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes.

Authors:  G Sudhandiran; Chandrima Shaha
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

7.  Mechanism of amphotericin B resistance in Leishmania donovani promastigotes.

Authors:  N Mbongo; P M Loiseau; M A Billion; M Robert-Gero
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

8.  Metabolomics to unveil and understand phenotypic diversity between pathogen populations.

Authors:  Ruben t'Kindt; Richard A Scheltema; Andris Jankevics; Kirstyn Brunker; Suman Rijal; Jean-Claude Dujardin; Rainer Breitling; David G Watson; Graham H Coombs; Saskia Decuypere
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

9.  Lipid biomarkers of lens aging.

Authors:  Bimal Prasanna Mohanty; Soma Bhattacharjee; Prasenjit Paria; Arabinda Mahanty; Anil Prakash Sharma
Journal:  Appl Biochem Biotechnol       Date:  2012-11-21       Impact factor: 2.926

10.  Leishmania chagasi naturally resistant to nitric oxide isolated from humans and dogs with visceral leishmaniasis in Brazil.

Authors:  P L Santos; R V Costa; J M Braz; L F V C Santos; A C Batista; C R O Vasconcelos; M R Rangel; A Ribeiro de Jesus; T R de Moura; P T G Leopoldo; R P Almeida
Journal:  Nitric Oxide       Date:  2012-04-28       Impact factor: 4.427

View more
  13 in total

1.  Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

Authors:  Maya Berg; Raquel García-Hernández; Bart Cuypers; Manu Vanaerschot; José I Manzano; José A Poveda; José A Ferragut; Santiago Castanys; Jean-Claude Dujardin; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.

Authors:  Tatiana R de Moura; Micheli Luize Barbosa Santos; Juciene M Braz; Luis Felipe V C Santos; Matheus T Aragão; Fabricia A de Oliveira; Priscila L Santos; Ângela Maria da Silva; Amélia Ribeiro de Jesus; Roque P de Almeida
Journal:  Parasitol Res       Date:  2016-02       Impact factor: 2.289

3.  Leishmania donovani chaperonin 10 regulates parasite internalization and intracellular survival in human macrophages.

Authors:  Lucie Colineau; Joachim Clos; Kyung-Mee Moon; Leonard J Foster; Neil E Reiner
Journal:  Med Microbiol Immunol       Date:  2017-03-11       Impact factor: 3.402

4.  Correlation between glucose uptake and membrane potential in Leishmania parasites isolated from DCL patients with therapeutic failure: a proof of concept.

Authors:  Maritza Padrón-Nieves; Claudia Machuca; Emilia Díaz; Paulo Cotrim; Noris Rodriguez; Alicia Ponte-Sucre
Journal:  Parasitol Res       Date:  2014-03-27       Impact factor: 2.289

5.  Impact of Preservation Conditions on Fatty Acids, Xanthan Gum Production and Other Characteristics of Xanthomonas campestris pv. mangiferaeindicae IBSBF 2103.

Authors:  Graciete S Silva; Denilson J Assis; Janice I Druzian; Maria B P P Oliveira; Paulo L L Ribeiro; Soraia M Cordeiro; Cleber A Schmidt
Journal:  Indian J Microbiol       Date:  2017-08-14       Impact factor: 2.461

6.  Antimony resistance associated with persistence of Leishmania (Leishmania) infantum infection in macrophages.

Authors:  Lucas Sousa Magalhães; Lays Gisele Santos Bomfim; Camilla Natália Oliveira Santos; Priscila Lima Dos Santos; Diego Moura Tanajura; Michael Wheeler Lipscomb; Amélia Ribeiro de Jesus; Roque Pacheco de Almeida; Tatiana Rodrigues de Moura
Journal:  Parasitol Res       Date:  2021-07-17       Impact factor: 2.289

7.  Changes in Lipid and Fatty Acid Composition During Intramacrophagic Transformation of Leishmania donovani Complex Promastigotes into Amastigotes.

Authors:  Hana Bouazizi-Ben Messaoud; Marion Guichard; Philippe Lawton; Isabelle Delton; Samira Azzouz-Maache
Journal:  Lipids       Date:  2017-02-04       Impact factor: 1.880

8.  Leishmanicidal Activity and Structure-Activity Relationships of Essential Oil Constituents.

Authors:  Audrey R S T Silva; Ricardo Scher; Flaviane V Santos; Sebastião R Ferreira; Sócrates C H Cavalcanti; Cristiane B Correa; Lilian L Bueno; Ricardo J Alves; Damião P Souza; Ricardo T Fujiwara; Silvio S Dolabella
Journal:  Molecules       Date:  2017-05-16       Impact factor: 4.411

Review 9.  Lipidomics and anti-trypanosomatid chemotherapy.

Authors:  Michael Biagiotti; Sedelia Dominguez; Nader Yamout; Rachel Zufferey
Journal:  Clin Transl Med       Date:  2017-08-01

10.  Non-Leishmania Parasite in Fatal Visceral Leishmaniasis-Like Disease, Brazil.

Authors:  Sandra R Maruyama; Alynne K M de Santana; Nayore T Takamiya; Talita Y Takahashi; Luana A Rogerio; Caio A B Oliveira; Cristiane M Milanezi; Viviane A Trombela; Angela K Cruz; Amélia R Jesus; Aline S Barreto; Angela M da Silva; Roque P Almeida; José M Ribeiro; João S Silva
Journal:  Emerg Infect Dis       Date:  2019-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.